Advantages of a targeted approach in minimally invasive radioguided parathyroidectomy surgery for primary hyperparathyroidism

Laryngoscope

Volumn 116, Issue 3, 2006, Pages 431-435

  Grady, Jennifer A ^a   Bumpous, Jeffrey M ^a,c   Fleming, Muffin M ^a   Flynn, Michael B ^a   Turbiner, Elliott ^b   Lentsch, Eric J ^a   Ziegler, Craig H ^a  

^a University of Louisville School of Medicine   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

Author keywords

Hyperparathyroidism diagnosis; Minimally invasive methods; Parathyroid hormone

Indexed keywords

CALCIUM; PARATHYROID HORMONE; DIAGNOSTIC AGENT; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT;

ADULT; ARTICLE; CALCIUM BLOOD LEVEL; CLINICAL TRIAL; COHORT ANALYSIS; FEMALE; HORMONE BLOOD LEVEL; HUMAN; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; MINIMALLY INVASIVE SURGERY; OPERATION DURATION; OUTCOMES RESEARCH; PARATHYROID GLAND; PARATHYROIDECTOMY; POSTOPERATIVE CARE; POSTOPERATIVE PERIOD; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; THYROID SCINTISCANNING; COMPARATIVE STUDY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FOLLOW UP; INTRAOPERATIVE PERIOD; METHODOLOGY; MIDDLE AGED; SCINTISCANNING; TREATMENT OUTCOME;

FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERPARATHYROIDISM, PRIMARY; INTRAOPERATIVE PERIOD; MALE; MIDDLE AGED; PARATHYROIDECTOMY; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; SURGICAL PROCEDURES, MINIMALLY INVASIVE; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED; TREATMENT OUTCOME;

EID: 33645516566     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mlg.0000195288.06601.18     Document Type: Article

References (15)

1. Vassy WM, Nelson HS, Mancini ML, Timaran CH, Hall NC, Smith GT. Minimally invasive parathyroidectomy: how effective is preoperative sestamibi scanning? Am Surg 2003;69:1090-1094.
2. Song AU, Phillips TE, Edmond CV, Moore DW, Clark SK. Success of preoperative imaging and unilateral neck exploration for primary hyperparathyroidism. Otolaryngol Head Neck Surg 1999;121:393-397.
3. McGreal G, Winter DC, Sookhai S, et al. Minimally invasive, radioguided surgery for primary hyperparathyroidism. Ann Surg Oncol 2001;8:856-860.
4. Goss JC, Landerholm R. A changing experience with primary hyperparathyroidism at Group Health Cooperative, Seattle. Am J Surg 2001;181:445-449.
5. Norman J, Chheda H, Farrell C. Minimally invasive parathyroidectomy for primary hyperparathyroidism: decreasing operative time and potential complications while improving cosmetic results. Am Surg 1998;64:391-396.
6. Norman J, Chheda H. Minimally invasive parathyroidectomy facilitated by intraoperative nuclear mapping. Surgery 1997;122:998-1004.
7. Flynn MB, Bumpous JM, Schill K, McMasters KM. Minimally invasive radioguided parathyroidectomy. J Am Coll Surg 2000;191:24-31.
8. Taillefer R, Boucher Y, Potvin C, et al. Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99m-sestamibi (double-phase study). J Nucl Med 1992;33:1801-1807.
9. Lundgren EC, Gillott AR, Wiseman JS, et al. The role of preoperative localization in primary hyperparathyroidism. Am Surg 1995;61:393-396.
10. Katz SC, Wand GJ, Kramer EL, Roses DF. Limitations of technetium 99m sestamibi scintigraphic localization for primary hyperparathyroid associated with multiglandular disease. Am Surg 2003;69:170-175.
11. Burkey SH, Van Heerden JA, Farley DR, Thompson GB, Grant CS, Curlee KJ. Will directed parathyroidectomy utilizing the gamma probe or intraoperative parathyroid hormone assay replace bilateral cervical exploration as the preferred operation for primary hyperparathyoidism? World J Surg 2002;26:914-920.
12. Casas AT, Burke GJ, Mansberger AR, Wei JP. Impact of technetium-99m- sestamibi localization on operative time and success of operations for primary hyperparathyroidism. Am Surg 1994;60:12-17.
13. Takami H, Ikeda Y, Wada N. Surgical management of primary hyperparathyroidism. Biomed Pharmacother 2000;54(suppl 1):17-20.
14. Udelsman R. Six hundred fifty-six consecutive explorations for primary hyperparathyroidism. Ann Surg 2002;235:665-672.
15. Merlino JI, Ko K, Minotti A, McHenry CR. The false negative technetium-99m-sestamibi scan in patients with primary hyperparathyroidism: correlation with clinical factors and operative findings. Am Surg 2003;69:225-230.